UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 16, pp. 1515 - 1525
Biological and medical sciences | General aspects | Medical sciences | Dermatology | Hair and nails disorders | Injections, Intralesional | Alopecia Areata - therapy | Humans | Immunosuppressive Agents - therapeutic use | Immunotherapy | Dermatitis, Contact | Hair Follicle - immunology | Alopecia Areata - diagnosis | Alopecia Areata - genetics | Alopecia Areata - immunology | Hair - growth & development | Care and treatment | Alopecia | Baldness | Medical case management | Causes of | Diagnosis | Methods | Vitiligo | Disease | Thyroid diseases | Stem cells | Hair loss | Autoimmune diseases | Medical disorders | Age | Index Medicus | Abridged Index Medicus
Journal Article
International journal of dermatology, ISSN 0011-9059, 02/2007, Volume 46, Issue 2, pp. 121 - 131
Life Sciences & Biomedicine | Dermatology | Science & Technology | Biological and medical sciences | Medical sciences | Hair and nails disorders | Glucocorticoids - therapeutic use | Vasodilator Agents - therapeutic use | Humans | Dermatologic Agents - therapeutic use | Alopecia Areata - etiology | Minoxidil - therapeutic use | PUVA Therapy | Alopecia Areata - therapy | Immunotherapy | Adult | Alopecia Areata - pathology | Anthralin - therapeutic use | Child | Index Medicus
Journal Article
British journal of dermatology (1951), ISSN 0007-0963, 05/2012, Volume 166, Issue 5, pp. 916 - 926
Life Sciences & Biomedicine | Dermatology | Science & Technology | Biological and medical sciences | Medical sciences | Hair and nails disorders | Alopecia Areata - etiology | Immunotherapy - methods | Aromatherapy - methods | Hypnosis - methods | Alopecia Areata - therapy | Humans | Prostheses and Implants | Laser Therapy - methods | Dermatologic Agents - therapeutic use | Alopecia Areata - diagnosis | Alopecia | Index Medicus
Journal Article
Cochrane library, ISSN 1469-493X, 2008, Volume 2020, Issue 10, pp. CD004413 - CD004413
Disorders of hair & nails | 1. Medical treatments | Alopecia Areata | H. DISORDERS OF SKIN APPENDAGES (HAIR, NAILS, SWEAT GLANDS) | Treatment Outcome | Skin disorders | Randomized Controlled Trials as Topic | topical immunotherapy (e.g. diphencyprone) | minoxidil | Medicine General & Introductory Medical Sciences | Hair loss | H12 Hair loss e.g. alopecia areata ("alopecia"), androgenic alopecia (male-pattern balding) | systemic corticosteroids | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Alopecia Areata - therapy | Humans | Index Medicus
Journal Article
The Journal of investigative dermatology symposium proceedings, ISSN 1087-0024, 12/2013, Volume 16, Issue 1, pp. S13 - S15
Journal Article
British journal of dermatology (1951), ISSN 0007-0963, 06/2017, Volume 176, Issue 6, pp. 1649 - 1652
Life Sciences & Biomedicine | Dermatology | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Immunotherapy - adverse effects | Neoplasm Metastasis | B7-H1 Antigen - antagonists & inhibitors | Melanoma - drug therapy | Adult | Female | Aged | CTLA-4 Antigen - antagonists & inhibitors | Carcinoma, Renal Cell - drug therapy | Drug Therapy, Combination | Kidney Neoplasms - drug therapy | Alopecia Areata - chemically induced | Cancer patients | Care and treatment | Management science | Alopecia | Baldness | Psoriasis | Cell death | Analysis | Immunotherapy | Monoclonal antibodies | Exanthema | Cytotoxicity | Lymphocytes T | Pruritus | Proteins | Literature reviews | Hepatitis | Vitiligo | Eruptions | Rosacea | Hair | Immune response | Quality of life | Pneumonitis | Immune checkpoint | PD-L1 protein | Colitis | Hair loss | Cancer | Apoptosis | PD-L1 | CTLA-4 | alopecia areata | PD-1 | VEGF
Journal Article
BMJ, ISSN 0959-8138, 2010, Volume 341, Issue 7766, pp. 242 - 246
Hair | CLINICAL REVIEW | Relapse | Alopecia | Corticosteroids | Scalp | Dermatology | Regrowth | Experimentation | Disease remission | Alopecia areata | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Diagnosis, Differential | Immunotherapy - methods | Off-Label Use | Adjuvants, Immunologic - administration & dosage | Prognosis | Dermatologic Agents - administration & dosage | Humans | Alopecia Areata - diagnosis | Randomized Controlled Trials as Topic | Alopecia Areata - etiology | Alopecia Areata - therapy | Administration, Topical | Adrenal Cortex Hormones - administration & dosage | Disease management | Hair loss | Medical treatment | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 04/2020, Volume 80, Issue 7, pp. 635 - 646
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Janus Kinases - antagonists & inhibitors | Alopecia Areata - metabolism | Antibodies, Monoclonal, Humanized - adverse effects | Janus Kinase Inhibitors - adverse effects | Janus Kinase Inhibitors - pharmacology | Animals | Alopecia Areata - drug therapy | Antibodies, Monoclonal, Humanized - pharmacology | Humans | Ustekinumab - pharmacology | Janus Kinases - metabolism | Ustekinumab - adverse effects | Drugs | Phosphorylation | Baldness | Cytokines | Clinical trials | Case reports | Transplants | Cytotoxicity | Arthritis | Kinases | Dermatitis | Alopecia | Molecular modelling | Lymphocytes | Janus kinase | Tumor necrosis factor-TNF | Hair loss | Autoimmune diseases
Journal Article